000181972 001__ 181972
000181972 005__ 20241220120851.0
000181972 0247_ $$2doi$$a10.1002/ijc.34308
000181972 0247_ $$2pmid$$apmid:36196489
000181972 0247_ $$2ISSN$$a0020-7136
000181972 0247_ $$2ISSN$$a1097-0215
000181972 0247_ $$2altmetric$$aaltmetric:136808609
000181972 037__ $$aDKFZ-2022-02334
000181972 041__ $$aEnglish
000181972 082__ $$a610
000181972 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000181972 245__ $$aPersonal Comorbidities and their Subsequent Risks for Liver, Gallbladder and Bile Duct Cancers.
000181972 260__ $$aBognor Regis$$bWiley-Liss$$c2023
000181972 3367_ $$2DRIVER$$aarticle
000181972 3367_ $$2DataCite$$aOutput Types/Journal article
000181972 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675340496_2343
000181972 3367_ $$2BibTeX$$aARTICLE
000181972 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181972 3367_ $$00$$2EndNote$$aJournal Article
000181972 500__ $$a#EA:C020# / 2023 Mar 15;152(6):1107-1114
000181972 520__ $$aMany environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and non-alcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80-100 in men and women diagnosed with hepatitis C virus and they were also > 10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and non-alcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, non-hepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. This article is protected by copyright. All rights reserved.
000181972 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000181972 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181972 650_7 $$2Other$$aHepatocellular carcinoma
000181972 650_7 $$2Other$$aalcohol
000181972 650_7 $$2Other$$acomorbidity
000181972 650_7 $$2Other$$afamilial risk
000181972 650_7 $$2Other$$arisk factor
000181972 650_7 $$2Other$$asmoking
000181972 7001_ $$aSundquist, Kristina$$b1
000181972 7001_ $$aSundquist, Jan$$b2
000181972 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b3$$udkfz
000181972 7001_ $$aLiska, Vaclav$$b4
000181972 7001_ $$00000-0001-7103-8530$$aHemminki, Akseli$$b5
000181972 7001_ $$aLi, Xinjun$$b6
000181972 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.34308$$gp. ijc.34308$$n6$$p1107-1114$$tInternational journal of cancer$$v152$$x0020-7136$$y2023
000181972 8767_ $$82022 (V10366)$$92022-06-23$$d2024-12-19$$eHybrid-OA$$jZahlung erfolgt
000181972 909CO $$ooai:inrepo02.dkfz.de:181972$$pVDB$$pOpenAPC$$popenCost
000181972 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000181972 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000181972 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000181972 9141_ $$y2022
000181972 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-02-04$$wger
000181972 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000181972 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000181972 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000181972 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000181972 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2022$$d2023-10-21
000181972 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2022$$d2023-10-21
000181972 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000181972 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000181972 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000181972 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000181972 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x2
000181972 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000181972 980__ $$ajournal
000181972 980__ $$aVDB
000181972 980__ $$aI:(DE-He78)C020-20160331
000181972 980__ $$aI:(DE-He78)HD01-20160331
000181972 980__ $$aI:(DE-He78)B062-20160331
000181972 980__ $$aUNRESTRICTED
000181972 980__ $$aAPC